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and promote the metastatic colonization. Analysis of clinical specimens showed a strong inverse correlation between levels of CCL15 and SMAD4; metastases that expressed CCL15 contained 3-fold more CCR1+ cells than those without CCL15. Patients with CCL15-expressing metastases showed significantly shorter disease-free survival (DFS) than those with CCL15-negative metastases.
CCR1+ cells in the metastases expressed the myeloid cell markers CD11b and myeloperoxidase, and also MMP9.
CONCLUSIONS:
In human CRC cells, loss of SMAD4 leads to upregulation of CCL15 expression. Human liver metastases with CCL15 expression contain higher numbers CCR1+ cells and these patients are associated with shorter DFS. Therapeutics that block CCL15 recruitment of CCR1+ cells may prevent metastasis of CRC to liver.
